Search Results - "Torres, MI"

Current view of the immunopathogenesis in inflammatory bowel disease and its implications for therapy by Torres, M-I, Rios, A

“…Although the aetiology of inflammatory bowel disease （IBD） remains unknown, the pathogenesis is gradually being unravelled, seeming to be the result of a…”
Get full text

Potential role of the IL-33/ST2 axis in celiac disease by López-Casado, M A, Lorite, P, Palomeque, T, Torres, M I

“…The IL-33/ST2 axis has been implicated in the pathogenesis of several tissue-specific autoimmune diseases. Celiac disease （CD） is the only autoimmune disease…”
Get full text

B383 Botulinum toxin infiltration as an option for treatment of persistent headache associated with COVID-19. Case report by Medina Torres, MI, Martín Santiago, S, Santos Macias, A

“…Background and AimsDifferent descriptions of long COVID have already been proposed, and the most common description includes symptoms lasting for over three…”
Get full text

New aspects in celiac disease by Torres, MI

“…Celiac disease （CD） is a common autoimmune disorder characterized by an immune response to ingested gluten and has a strong HLA association with HLA-DQ2 and…”
Get full text

4CPS-088 Indirect comparison of nivolumab, pembrolizumab and camrelizumab in patients with unresectable and/or advanced squamous cell carcinoma of the oesophagus in a second-line setting by Pérez Cano, E, Jiménez López, Y, Sierra Torres, MI, Pérez Cano, R

“…Background and importanceEstablished treatment for advanced, recurrent or unresectable oesophageal squamous cell cancer (ESCC) includes systemic therapy,…”
Get full text

In-vitro radiosensitivity in patients with systemic lupus erythematosus by Carrillo-Alascio, PL, Sabio, JM, Núñez-Torres, MI, López, E, Muñoz-Gámez, JA, Hidalgo-Tenorio, C, Jáimez, L, Martín, J, Jiménez-Alonso, J

“…To determine the “in-vitro” intrinsic cell radiosensitivity (RS) as a risk indicator of radiation-related side-effects in patients with systemic lupus…”
Get full text

5PSQ-138 Chemotherapy errors detected during pharmaceutical validation by Sánchez Argaiz, MC, Gándara Ladrón de Guevara, MJ, Sierra Torres, MI, Montero Vilchez, C, Jimenez Morales, A

“…Background and ImportanceChemotherapy errors represent a potentially serious risk of patient harm because of the narrow therapeutic window of antineoplastic…”
Get full text

5PSQ-070 Usefulness of pharmaceutical validation in chemotherapy prescriptions by Sánchez Argaiz, MC, Sierra Torres, MI, Gándara Ladrón de Guevara, MJ, Espinosa Rodriguez, A, Jiménez Morales, A

“…Background and importanceOne of the most frequent complications of antineoplastic treatment is the drugs’ toxicity, which can lead to temporary or definitive…”
Get full text

3PC-025 Magistral formulation for a patient with multiple food allergy by Jiménez López, Y, Pérez Cano, E, Merino Almazán, M, Claramunt García, R, Sierra Torres, MI, Caba Porras, I

“…Background and importanceMultiple food allergy (MFA), in its severe stage, is a pathology with nutritional and pharmacotherapeutic restrictions. Drug…”
Get full text

1ISG-008 Economic impact of the use of biosimilar infliximab in a second-level hospital by Mora, AB Morillo, Rosa, V Gonzalez, Torres, MI Sierra

“…BackgroundThe high price of biological drugs has become progressively unsustainable to the national health system. The development of biosimilar drugs might…”
Get full text

5PSQ-006 Use of substitute enzymatic treatment and substrate reduction in gaucher disease by González Rosa, V, Sierra Torres, MI, Fernández Espínola, S, Zaragoza Rascón, M, Pajares Alonso, M

“…BackgroundGaucher disease is included within lipidosis that occur due to mutations in the gene encoding the enzyme ß-glucosidase. As a result of this, a fatty…”
Get full text

5PSQ-074 Canakinumab in familial mediterranean fever and secondary amyloidosis: a case report by González Rosa, V, Sierra Torres, MI, Fernández Espínola, S, Zaragoza Rascón, M, Pajares Alonso, M

“…BackgroundFamilial mediterranean fever (FMF) is an autosomal recessive disease characterised by repeated and self-limited seizures of fever and serositis…”
Get full text

5PSQ-027 Effectiveness and safety of tolvaptan and urea for the treatment of severe symptomatic hyponatraemia: a case series by Maria Belen, FI, Valera Rubio, M, Sierra Torres, MI, Estaun, C, Moya-Carmona, I, Fernández Ovies, JM

“…BackgroundTolvaptan and, recently, urea were both indicated for the treatment of hyponatraemia secondary to the Syndrome of Inappropriate Antidiuretic Hormone…”
Get full text

5PSQ-010 Efficacy and safety of agalsidase alfa in fabry disease by Rosa, V González, Gil, E Atienza, Torres, MI Sierra, Rascón, M Zaragoza, Alonso, M Pajares

“…BackgroundFabry disease is included within the lipid deposition diseases that occur due to mutations in the gene that encodes the α-galactosidase enzyme. As a…”
Get full text

5PSQ-051 Effectiveness and safety of snake antivenom: a case report by Rosa, V González, Gil, E Atienza, Torres, MI Sierra, Mora, AB Morillo, Alonso, M Pajares, Rascon, MZaragoza

“…BackgroundAntivenom immunoglobulin is a medication made up of antibodies used to treat snake bites.PurposeTo describe the effectiveness and safety of snake…”
Get full text

4CPS-067 Assessment of the effectiveness of using vancomycin in patients undergoing haemodyalisis by Torres, MI Sierra, Navarro, MV Gil, Bueno, C Villanueva, Hidalgo, L Herrera

“…BackgroundVancomycin is used commonly to treat Gram +bacteraemia in haemodialysis patients. The most accurate and practical method to monitor vancomycin…”
Get full text

5PSQ-004 Adequacy and effectiveness of liraglutide in patients with type-2 diabetes mellitus by Rosa, V González, Torres, MI Sierra, Gil, E Atienza, Mora, AB Morillo, Alonso, M Pajares, Rascón, MZaragoza

“…BackgroundLiraglutide is a human glucagon-like peptide-1 analogue (GLP-1) indicated in the treatment of adults with type-2 diabetes mellitus to achieve…”
Get full text

3PC-014 Stability study of gentamicin lock therapy with heparin or citrate as anticoagulant by Bueno, C Villanueva, Padillo, JA Noval, Sacaluga, L Gil, Gil-Bermejo, J Molina, Torres, MI Sierra, Hidalgo, L Herrera, Gil, AB Guisado, Navarro, MV Gil

“…BackgroundThe antibiotic lock therapy (ALT) technique that involves the instillation of a highly concentrated antimicrobial solution with additives such as…”
Get full text

CP-157 Risk factors associated with thromboembolic disease in hospitalised patients: an assessment in a general specialties hospital by Torres, MI Sierra, Soto, CM Valencia, del Moral, R Sánchez, Guzmán, MD Toscano, Gómez, E Sánchez, Martín, C Bocanegra

“…BackgroundThromboembolic disease (TED) is a complex condition in which the interaction between genetic, acquired and environmental factors determines the onset…”
Get full text

PS-008 Degree of compliance with the standards of high alert medications established by the institute for safe medication practices in a secondary hospital by Madroñal, IM Carrion, Gomez, E Sanchez, del Moral, R Sanchez, Mancha, MT Lopez, Torres, MI Sierra, Martin, C Bocanegra

“…BackgroundHigh alert medications are drugs that bear a heightened risk of causing significant patient harm when used in error. The Institute for Safe…”
Get full text